Overview

Glyconanoparticles, adorned with carbohydrate molecules, enhance their biocompatibility and targeting capabilities, making them ideal for drug delivery, vaccine development, and targeting specific cells like cancer cells. Through a detailed evaluation of their drug delivery efficiency, safety, and cell interactions using various in vitro models, we optimize glyconanoparticle formulations, facilitating their transition to targeted therapeutic applications. CD BioGlyco, leveraging the established GlycoNano™ Platform, offers a customizable in vitro model-based evaluation service for glyconanoparticle delivery. These comprehensive Preclinical Studies provide reliable support for the use of glyconanoparticles in biomedical and drug-delivery contexts.

Your Most Satisfied Partner for In Vitro Models for Glyconanoparticle Delivery Evaluation

We offer a range of in vitro cell models specifically designed for testing and evaluating the potential of glyconanoparticles in targeted drug delivery. These models are crucial in studying and developing efficient therapeutic approaches. Our overall service process encompasses the following key steps:

Development of Glyconanoparticle

We rationalize the design of glyconanoparticles based on monomer composition, synthesis method, detailed application, etc. After the synthesis of glyconanoparticles, unreacted compounds, and other impurities are removed by dialysis, centrifugation, etc., to obtain high-quality glyconanoparticles. The size of glyconanoparticle is the most important parameter to determine cell uptake, drug loading, and delivery efficiency. We optimize to achieve minimum size and maximum loading.

Characterization of Glyconanoparticle

After preparation, we performed a comprehensive and detailed characterization of glyconanoparticles for rational analysis of glyconanoparticles in drug-targeted delivery. The characterization of glyconanoparticle includes but is not limited to the following:

• Measurement of the particle size and size distribution of glyconanoparticles by dynamic light scattering (DLS)
• Morphological study of glyconanoparticles by scanning electron microscope (SEM) and atomic force microscopy (AFM)
• Structural characterization of glyconanoparticles by Fourier transform infrared spectroscopy (FTIR), and nuclear magnetic resonance (NMR)

In Vitro Preclinical Studies of Glyconanoparticle

Available in vitro models include specific cancer cell lines expressing the targeted glycan receptor and normal cell lines to better mimic in vivo conditions. In addition to the models below, if you have other in vitro cell models of interest, our dedicated team offers model customization services to meet your research needs.

• After binding glyconanoparticles to a drug, their ability to enter cells is assessed by in vitro cell assays (flow cytometry, fluorescent labeling, etc.). The interactions between glyconanoparticles and cells, including cell uptake, internalization pathways, and intracellular distribution, are also studied. These analyses reveal the delivery mechanism of glyconanoparticles as drug carriers.
• The release rate and release profile of glyconanoparticle-encapsulated drugs are evaluated in vitro under simulated physiological conditions, and data are provided to support further understanding of drug release behavior in vivo.
• We assess the biological activity of the released drug on cells, including the effects on cell survival, morphology, cell proliferation, and apoptosis.
• We assess the toxic effects of glyconanoparticles and the drugs they carry on cells by assaying indicators such as cell survival, apoptosis, and changes in cell morphology. The immune response to glyconanoparticles is assessed by detecting cytokine release, etc.

Workflow

We provide a professional glyconanoparticle drug delivery assessment service based on various in vitro cell models to optimize glyconanoparticle formulations and advance targeted therapy research. In addition, we also provide comprehensive analytical support including statistical analysis, data-based optimization of glyconanoparticle formulations, and actionable insights for further research.

Applications

• Our in vitro cell model is used to evaluate the efficiency and specificity of glyconanoparticle delivery of therapeutic agents to target cells. Through the rational design and modification of glyconanoparticles, researchers can enhance drug uptake by cells expressing the corresponding receptors.
• Our in vitro cell model is used to study the kinetic characteristics of glyconanoparticles for drug release, thereby optimizing the particle design for sustained or triggered release of therapeutic drugs.
• Our in vitro cell models are used to evaluate the potential of glyconanoparticles to deliver RNA or DNA in gene therapy.

Advantages

• Our years of proven experience in cell culture and glyconanoparticle application evaluation ensures customized experimental protocols and maximum satisfaction with our client's research needs.
• We provide one-stop glyconanoparticle research services, including glyconanoparticle design, preparation, characterization, and drug delivery evaluation using in vitro models.
• Our professional team of data analysts is responsible for the detailed analysis of data and writing of study reports.

Publication Data

Frequently Asked Questions

• What cell uptake studies do you perform?
  We perform a variety of cell uptake studies using flow cytometry, laser confocal microscopy, and other techniques to quantify and observe the uptake of glyconanoparticles by target cells.
• How do you assess the cytotoxicity of glyconanoparticles?
  We use a variety of cytotoxicity assays, including MTT, LDH release, Annexin V/PI assay, etc., to assess the effects of glyconanoparticles on cell viability and apoptosis.

CD BioGlyco specializes in evaluating glyconanoparticle drug delivery using various in vitro models, which is essential for advancing the development of drug delivery systems and the study of various therapeutic strategies. Please feel free to contact us to discuss further experimental information if you are interested in this area or have any special requirements. We look forward to helping you better explore the potential applications of glyconanoparticles.